As Biogen hunts for a turnaround CEO, execs sketch out a hazy look at an uncertain new future

Once again, Biogen’s board of directors is looking to execute a brisk turnaround in order to satisfy investors that it has a solid footing and a clear road ahead to grow revenues again, instead of managing a shrinking revenue stream from aging products.

Bioregnum Opinion...

Click to view original post